Depaquit Thibaut Long, Aguëro Christopher, Uleri Alessandro, Jourdan Marvin, Fourmarier Marc, Gondrand-Tellier Bastien, Delonca Raphaëlle, Tnibar Omar, Peyrottes Arthur, Laroche Julien, Molimard Benoit, Bastide Cyrille, Baboudjian Michael
Department of Urology, Hôpital d'Instruction des Armées Sainte-Anne, Toulon, France.
Department of Urology, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
World J Urol. 2025 Jun 20;43(1):379. doi: 10.1007/s00345-025-05747-6.
Nocturia may be one of the most persistent and bothersome lower urinary tract symptoms (LUTS) in men treated for benign prostatic obstruction (BPO). This study aimed to evaluate the evolution of nocturia after endoscopic enucleation of the prostate (EEP) and identify predictors of no postoperative improvement.
We conducted a multicenter retrospective study of 120 men who underwent EEP for LUTS/BPO and nocturia evaluation using voiding diaries. Patients with isolated nocturia were not considered for surgery. Outcomes were categorized into complete remission, partial improvement, stability, or worsening.
At a median follow-up of 15 months, 45% of patients achieved complete remission of nocturia, 19% experienced partial improvement, 30% remained stable, and 6% worsened. The median time for improvement was 6 months. Cox regression analysis identified predominant overactive bladder symptoms as the only significant predictor of no response (HR 1.68; 95% CI, 1.01-2.82; p = 0.04). No significant association was found with age, body mass index, prostate volume, or cardiometabolic comorbidities.
This multicenter study highlights that while nocturia often persists after EEP, nearly two-thirds of patients experience meaningful improvement, emphasizing both the potential benefit of surgery and the multifactorial nature of the symptom.
夜尿症可能是接受良性前列腺梗阻(BPO)治疗的男性中最持久且困扰人的下尿路症状(LUTS)之一。本研究旨在评估前列腺内镜剜除术(EEP)后夜尿症的演变情况,并确定术后无改善的预测因素。
我们对120例因LUTS/BPO接受EEP治疗且使用排尿日记进行夜尿症评估的男性进行了多中心回顾性研究。单纯夜尿症患者不纳入手术。结果分为完全缓解、部分改善、稳定或恶化。
中位随访15个月时,45%的患者夜尿症完全缓解,19%部分改善,30%保持稳定,6%恶化。改善的中位时间为6个月。Cox回归分析确定膀胱过度活动症为主的症状是无反应的唯一显著预测因素(HR 1.6 8;95%CI,1.01 - 2.82;p = 0.04)。未发现与年龄、体重指数、前列腺体积或心血管代谢合并症有显著关联。
这项多中心研究强调,虽然EEP后夜尿症常持续存在,但近三分之二的患者有显著改善,凸显了手术的潜在益处以及该症状的多因素性质。